Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Scapa Group is a global manufacturer and strategic outsource partner specializing in bonding solutions and adhesive components for the healthcare and industrial markets. Its healthcare division, Scapa Healthcare, operates as a leading Contract Development and Manufacturing Organization (CDMO) for the advanced wound care, ostomy, and medical device markets. The company provides comprehensive services including design, development, cleanroom manufacturing, and specialized packaging. Scapa is particularly noted for its expertise in skin-contact technologies, such as hydrocolloids, hydrogels, and medical-grade adhesives. In 2021, the company was acquired by Schweitzer-Mauduit International (SWM), which subsequently merged with Neenah to form Mativ. Today, Scapa continues to support global medical device and pharmaceutical companies with innovative material science and manufacturing solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Scapa Group.